Abstract
TMT consists of a maximal resection of the bladder, followed by a concurrent radiotherapy and chemotherapy, limiting salvage radical cystectomy to non-responder tumours or muscle-invasive recurrence (Mathieu et al., Curr Opin Urol 25:476–482, 2015). This chapter is an introduction to trimodal therapy in bladder cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mathieu R, Lucca I, Klatte T, Babjuk M, Shariat SF. Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy? Curr Opin Urol. 2015;25(5):476–82.
Lee CY, Yang KL, Ko HL, Huang RY, Tsai PP, Chen MT, Lin YC, Hwang TI, Juang GD, Chi KH. Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival. Radiat Oncol. 2014;9:213.
Ploussard G, Daneshmand S, Efstathiou JA, Herr HW, James ND, Rödel CM, Shariat SF, Shipley WU, Sternberg CN, Thalmann GN, Kassouf W. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur Urol. 2014;66(1):120–37.
Russell CM, Lebastchi AH, Borza T, Spratt DE, Morgan TM. The role of transurethral resection in trimodal therapy for muscle-invasive bladder cancer. Bladder Cancer. 2016;2(4):381–94.
Takaoka EI, Miyazaki J, Ishikawa H, Kawai K, Kimura T, Ishitsuka R, Kojima T, Kanuma R, Takizawa D, Okumura T, Sakurai H, Nishiyama H. Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer. Jpn J Clin Oncol. 2017;47(1):67–73.
Kulkarni GS, Hermanns T, Wei Y, Bhindi B, Satkunasivam R, Athanasopoulos P, Bostrom PJ, Kuk C, Li K, Templeton AJ, Sridhar SS, van der Kwast TH, Chung P, Bristow RG, Milosevic M, Warde P, Fleshner NE, Jewett MAS, Bashir S, Zlotta AR. Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic. J Clin Oncol. 2017;35(20):2299–305.
Williams SB, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Huo J, Senagore AJ, Orihuela E, Tyler DS, Swanson TA, Kamat AM. Comparing survival outcomes and costs associated with radical cystectomy and trimodal therapy for older adults with muscle-invasive bladder cancer. JAMA Surg. 2018;153:881.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Goonewardene, S.S., Ventii, K., Bahl, A., Persad, R., Motiwala, H., Albala, D. (2021). Trimodal Therapy in Bladder Cancer. In: Management of Muscle Invasive Bladder Cancer. Management of Urology. Springer, Cham. https://doi.org/10.1007/978-3-030-57915-9_27
Download citation
DOI: https://doi.org/10.1007/978-3-030-57915-9_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57914-2
Online ISBN: 978-3-030-57915-9
eBook Packages: MedicineMedicine (R0)